DETECTION TEST ASSEMBLY FOR DETECTING THE PRESENCE OF A SUBSTANCE IN A SAMPLE

• US 20090263905A1
• Filed: 04/18/2008
• Published: 10/22/2009
• Est. Priority Date: 04/18/2008
• Status: Abandoned Application

• Current Assignee: Kim Scheuringer
• Original Assignee: Kim Scheuringer
• Inventors: Scheuringer, Kim
• Application Number:
  US12/105,590
• Publication Number:
  US 20090263905A1
• Time in Patent Office: Days
• US Class Current: 436/66
• CPC Class Codes: G01N 33/72 involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood

Abstract

A detection test assembly for detecting the presence of a substance preferably a blood substance in a feces sample comprising feces diluted in buffer solution or water is described. The blood substance is detected by acceptors having binding properties for the substance or that may be specifically bound by the substance. Said assembly comprises a reaction field having a mobile first acceptor with visualization properties and a detection field comprising a test field connected to and located downstream from the reaction field having an immobilized second acceptor. After direct application of a prepared feces sample to the assembly, first acceptor forms a complex with blood substance, flows to test field and binds to or is bound by immobilized second acceptor. Accumulation of first acceptor in the test field results in the formation of a visualizable line such as color different from the color of the test field itself. The detection test assembly includes at least two positive internal controls.

Claims

1. A detection test assembly for detecting a substance in a sample, the substance having a first substance portion and a second substance portion, comprising:

a reaction field comprising a first acceptor, wherein said first acceptor is mobile and has a visualization property, and wherein a specific binding affinity exists between said first acceptor and the first portion of said substance such that a first acceptor-substance complex may be formed; and

a detection field comprising a test field, and at least a first control field, wherein the test field has a second acceptor, wherein said second acceptor is immobilized on the test field and wherein a specific binding affinity exists between at least one of;

(i) said second acceptor; and

at least one of (a) the second portion of said substance and (b) a portion of the first acceptor-substance complex formed by first acceptor and the first portion of said substance; and

wherein the first control field is connected to the test field, wherein the first control field has an immobilized third acceptor, and wherein said third acceptor has a specific binding affinity for a ubiquitous sample component, other than the substance to be detected by the detection test assembly.

2. The detection test assembly of claim 1, further comprising a second control field connected to the first control field or the test field, wherein the second control field has an immobilized fourth acceptor, and wherein said fourth acceptor has a specific binding affinity for a component in the detection test assembly, other than the substance to be detected by the detection test assembly or the ubiquitous sample component to be detected by the third acceptor, and having a visualization property.

3. The detection assembly of claim 1, wherein said first portion of said substance is on a location different from said second portion of said substance so that said first acceptor, said second acceptor and said substance may be specifically bound together simultaneously.

4. The detection assembly of claim 1, wherein said first acceptor does not have a specific binding affinity for said second acceptor and said second acceptor does not have a specific binding affinity for said first acceptor;

and wherein the test field is connected to and located downstream from the reaction field.

5. The detection test assembly of claim 1, further comprising a supporting backing.

6. The detection test assembly of claim 5, wherein said supporting backing is selected from the group consisting of plastic, glass and paper.

7. The detection test assembly of claim 6, wherein said supporting backing is plastic and said plastic is at least one polyester sheet, and wherein said polyester sheet is glued to the reaction field and the detection field.

8. The detection test assembly of claim 1, further comprising a sample application field connected to and located upstream of the reaction field.

9. The detection test assembly of claim 8 wherein the sample application field is fibreglass.

10. The detection test assembly of claim 1 further comprising a soaking field connected to and located downstream from the detection field, wherein said soaking field comprises a porous material for absorbing an excess of the sample.

11. The detection test assembly of claim 1, wherein the visualization property of said first acceptor is a label conjugated to the first acceptor.

12. The detection test assembly of claim 11, wherein said label is selected from the group consisting of colloidal gold, colored latex particle, magnetic particle, and a chemical color dye.

13. The detection test assembly of claim 1, wherein said first acceptor and said second acceptor are, individually, selected from the group consisting of monoclonal antibody, polyclonal antibody, and a combination of monoclonal antibody and polyclonal antibody.

14. The detection test assembly of claim 13 wherein said first acceptor is anti-beta-human hemoglobin monoclonal antibody labelled with colloidal gold and binds to said second acceptor which is an anti-alpha-human hemoglobin monoclonal antibody.

15. The detection test assembly of claim 14 further comprising a second control field connected to and located downstream from the test field and having an immobilized fourth acceptor that is an antibody having a specific binding affinity for the first acceptor.

16. The detection test assembly of claim 15 further comprising a sample application field and a soaking field, wherein said sample application field and said reaction field seamlessly and directly abut and are made of fibreglass, wherein said detection field seamlessly and directly abuts said reaction field and is made of nitrocellulose membrane, and said soaking field seamlessly and directly abuts said detection field and is made of one of the group selected from porous paper and silica gel matrix.

17. The detection test assembly of claim 1, further comprising a housing.

18. The detection test assembly of claim 17, wherein said housing is a cassette.

19. The detection test assembly of claim 18, wherein said cassette has a window for at least one of the group consisting of a sample application field, the test field and a control field.

20. The detection test assembly of claim 18, wherein said cassette has at least one of the group consisting of lettering on the cassette and an area dedicated for indicating information related to the feces sample of a subject.

21. A method of using the detection test assembly of claim 1, comprising at least the steps of:

preparing a sample by transferring the substance with an instrument into a container,

providing a buffer solution in the said container, wherein said buffer solution has a pH of about 4 to 10, more preferably of about 6 to 8, more preferably of about 7 to 7.8, and most preferably of about 7.4, and contains a preservative; and

applying the sample to a sample application field.

22. The detection test assembly of claim 1, wherein said second acceptor has a visualization property.

23. The detection test assembly of claim 22, wherein the visualization property of said second acceptor is a label conjugated to said second acceptor, wherein said label is at least one colored latex particle, and wherein said colored latex particle conjugated to the second acceptor has a color different from the colored latex particle conjugated to the first acceptor so that, when in use and in the presence of a detectable blood substance, a color of the test field formed by the label of the second acceptor is altered in a visualizable manner.

25. A detection test assembly of claim 32 further comprising a supporting backing and wherein said first acceptor has a visualization property.

26. A kit for detecting a blood substance in a prepared feces sample comprising at least one container containing a detection test assembly of claim 1.

27. The kit of claim 26 further comprising at least one of the group consisting of an instrument for transferring fecal matter, a second container for preparing the feces sample, a housing, and a buffer solution.

28. The kit of claim 26 further comprising a buffer solution wherein a volume of the buffer solution is pre-measured into the second container and wherein the second container is a closed container with a removable cap.

29. A method for detecting a blood substance in fecal matter comprising the steps of preparing a feces sample by diluting fecal matter with a buffer solution and applying the prepared feces sample to a DTA of claim 1.

30. The detection test assembly of claim 2, wherein the fourth acceptor is a competitive acceptor.

31. The detection test assembly of claim 1, wherein the ubiquitous sample component binds to a mobile first control acceptor, having a visualization property, located in the reaction field, creating a ubiquitous sample component—

first control acceptor complex.

32. The detection test assembly of claim 31, wherein said ubiquitous sample component—

first control acceptor complex binds to the third acceptor at the first control field via the ubiquitous sample component.

33. The detection test assembly of claim 2, wherein the fourth acceptor binds to at least one of the first acceptor;

a mobile second control acceptor having a visualization property;

or a sample substance at the second control field.

34. The detection test assembly of claim 31, wherein the mobile first control acceptor does not have a specific binding affinity for or by the substance to be detected by the DTA, the first acceptor, or the first acceptor-substance complex, the second acceptor, or the third acceptor.

35. The detection test assembly of claim 2, wherein the second control acceptor does not have a specific binding affinity for or by the substance to be detected by the DTA, the first acceptor, or the first acceptor-substance complex, the second acceptor, the ubiquitous sample component, the ubiquitous sample component—

first control acceptor complex, or the third acceptor.

24. A detection test assembly for detecting a blood substance in a feces sample, the substance having a first substance portion and a second substance portion, comprising:

a reaction field comprising a first acceptor, wherein said first acceptor is mobile and wherein said first acceptor and the first portion of said substance has a specific binding affinity for the other; and

a detection field comprising a test field, and at least a first control field and a second control field, the test field having a second acceptor, wherein said second acceptor is immobilized on the test field and wherein said second acceptor is bound to a competitive acceptor having a visualization property, and wherein there is specific binding affinity between least one of (i) said second acceptor and (ii) at least one of (a) the second portion of said substance and (b) a portion of a complex formed by the first portion of said first acceptor and the first portion of said substance that is different from the first acceptor alone; and

wherein said first portion of said substance is in a location different from said second portion of said substance so that said first acceptor, said second acceptor and said substance may be specifically bound together simultaneously; and

wherein said first acceptor does not have a specific binding affinity for said second acceptor and said second acceptor does not have a specific binding affinity for said first acceptor;

wherein the test field is connected to and located downstream from the reaction field;

wherein the first control field is connected to the test field, wherein the first control field has an immobilized third acceptor, and wherein said third acceptor has a specific binding affinity for a ubiquitous fecal matter component, other than the substance to be detected by the detection test assembly; and

wherein the second control field is connected to the first control field, wherein the second control field has an immobilized fourth acceptor, and wherein said fourth acceptor has a specific binding affinity for a component in the detection test assembly, other than the substance to be detected by the detection test assembly or the ubiquitous fecal matter component, and having a visualization property.